Try our Advanced Search for more refined results
Life Sciences - September, 2022
319 articles
- 3rd Circ. Orders Sentence Redo In $95M Drug Fraud Case
- The 5 Biggest Cases This Supreme Court Term
- $178M Verdict Against Novartis Stands But Can't Be Tripled
- Fla. Man's Silence Keeps Gilead's NY Counterfeiting Suit Alive
- BakerHostetler Accused Of Fraud In $100M Bankruptcy Suit
- Detroit Cannabis Licensing Unfair To Non-Residents, Suit Says
- Administrator Named In CVS-Walgreens-Walmart Opioid Order
- Law360's The Term: A New Normal For The Supreme Court?
- Health Hires: Nelson Mullins, Lyell Immunopharma
- No Signs Of Supreme Court's Conservatives Slowing Down
- How Well Do You Know Supreme Court History?
- UnitedHealth Merger Loss Is One Step In DOJ's Long Game
- Judge Adopts Report, Giving Medical Lab, Insurer Partial Wins
- UK Litigation Roundup: Here's What You Missed In London
- Justice Ketanji Brown Jackson Takes Bench, Makes History
- Keys To A 9-0 High Court Win: Practicality Over Perfection
- FTC Accuses Pesticide Giants Of 'Pay-To-Block' Scheme
- 5 Firms Guide $834M Chinese Biopharma SPAC Merger
- IP Forecast: Philip Morris Looks To Snuff Out ITC Ban
- Monster Wins $293M Verdict Against VPX In False Ad Trial
- Stimwave Gets Del. Ch. 11 OK For $124M Auction Offer
- High Court Halts Generic Gilenya As Novartis Appeals IP Loss
- 6th Circ. Affirms Ky. Clerk Liable In Gay Marriage License Suit
- Technology Co. Sues Insurers Over Wire Fraud Losses
- What New Bar Exam Means For Law Students And Schools
- Fed. Circ. Affirms PTAB Save Of Merck Diabetes Drug Patent
- Centene To Pay $14M To Settle Mass. Medicaid Fraud Claims
- C.R. Bard Can't Escape Trial In Illinois Pelvic Mesh Suit
- What USPTO's Disclosure Duties Notice Says And Doesn't Say
- Ill. City Says It Was 'Kicked' By Express Scripts' Doc Dump
- Chinese Pharma Co. Seeks OK Of $40M Arbitral Award
- Endo Opioid Claimants Question Their Slice Of Ch. 11 Deal
- Medicare's 340B Cuts For 2022 Must End Now, Judge Rules
- Workers Fight Pot Co. Curaleaf's Renewed Bid To Ax Tips Suit
- La. Health Clinic's Ex-CEO Convicted In Medicaid Fraud
- Apple's New Messaging Features Will Complicate E-Discovery
- Novartis Gets Counterclaims Cut From Heart Drug Patent MDL
- Pro-Choice Advocates Say Paxton Subpoena Saga Is His Fault
- Womble Bond Adds DC Partner Amid Patent Hiring Spree
- Paramedical Services Co. Hit With TCPA Suit Over Robocalls
- MVP: Williams & Connolly's David I. Berl
- Recent Cases Guide On Use Of Experts In Employment Trials
- Biogen Whistleblower's $250M Award 'Extraordinary' For FCA
- Fed. Circ. Won't Halt Gilenya Generics During Novartis Appeal
- Fed. Circ. Temporarily Pauses Launch Of Generic Lexiscan
- Seattle Cafe Drops 9th Circ. Virus Coverage Appeal
- Fastest AG In The West? Paxton Slips Service In Abortion Row
- The High Court Cases Health And Life Sci Attys Are Watching
- COVID-Focused Biotech Firm Eyeing $675M SPAC Merger
- Ex-Receptionist Says MRI Co. Fired Her For Reporting Abuse
- Law Firm Inclusion Efforts Often Overlook Business Staff
- UK Court OKs Stay For Mesh Suits Against Endo Unit
- Colorado High Court Says State Can't Sue Juul Execs
- Indiana Abortion Ban Challenged By Satanic Temple
- Travelers Has No Duty To Defend Northrop Pollution Suit
- Health Care Fraud Among New Philly US Atty's Top Concerns
- 2 Firms Seek $1.25M In Chancery Deal With Biotech Co., CEO
- BioNTech And Pfizer Want CureVac COVID Patents Nixed
- RICO Claims Against Cannabis Cos. Are Evolving
- L'Oreal Must Face False Ad Suit Over Collagen Products
- MVP: White & Case's Adam Acosta
- Biogen Finalizes $900M Deal To End Feds' Kickback Claims
- EEOC Sues Eli Lilly For Age Bias After Exec Touted Millennials
- Women At Ford, GE Outliers In Top Cos.' Wide IP Gender Gap
- Stay Mulled In Del. Suit Targeting Walmart Opioid Damages
- Eli Lilly Off The Hook In Trade Secrets Suit Over Migraine App
- Two Funds Seek Invidior Antitrust Docs In Securities Case
- Reexamining Negative Limitations After Novartis Patent Ruling
- Catching Up With Delaware's Chancery Court
- 3 Recent Cases Highlight Public Nuisance Climate Suits' Flaws
- Biotech Firm Says Competitor Spread Lies About Gender Test
- An Associate's Guide To Rebounding After A Layoff
- Investors Fight Hemp Co.'s Bid To Toss Stock-Drop Suit
- MVP: Quinn Emanuel's David Bilsker And David Perlson
- 3 Questions As Feds Flesh Out New Breach Reporting Rules
- Musk's Dim View Of Patents Ignores Reality For Most Cos.
- Stockholders Reach Far For Damages In Chancery Opioid Suit
- Jury Puts Stryker Biz On Hook For $17.2M In Bone Screw Fight
- J&J Wants 'Rapid Release' Tylenol Class Claims Tossed
- Judge Cuts Some Of Atum's Claims In Gene Therapy IP Row
- Ga. Judge Dismisses Ethylene Oxide Exposure Case
- 9th Circ. Overturns Insurer's Win In ERISA Benefits Suit
- AML Regulation Of Lawyers Is Imminent And Controversial
- Equally Split Full 4th Circ. Affirms Toss Of Allergan FCA Case
- 'I Lost A Lot': Breyer Opens Up On 'Frustrating' Last Term
- Jury Says LabCorp Owes $272M For Infringing Prenatal Test IP
- Bristol-Myers Must Face Celgene Deal Suit In NJ State Court
- J&J Unit Looks To Scrub BIPA Suit Over Skin Care App
- Pfizer Kickback Ruling Shows Drug Copay Program Risks
- UK Litigation Roundup: Here's What You Missed In London
- MVP: Covington's Amy Toro
- Sofia Vergara's Ex-Fiancé Can't Revive Pre-Embryo Suit
- Transplant Co. Hit With Investor Suit Over Bundling Probe
- Stimwave Director Calls For Investigation Of Ch. 11 Sale
- IP Forecast: Tyga's 'Wavy Baby' Shoe Row Goes To 2nd Circ.
- 1st Post-Dobbs Abortion Ban Is Blocked In Indiana
- Rutgers Defeats Challenge To COVID-19 Vaccine Mandate
- Life Sciences-Focused Blank-Check Firm DMB Pulls $75M IPO
- SG Tells Justices To Reject Amgen Patent Enablement Case
- What DOJ Enforcement Shift Means For Life Sciences Cos.
- Weighing Risk And Reward Of Cooperating In FCA Civil Cases
- PTAB Director Review Under Vidal: The First 6 Months
- Merck Gets Win In Patent Suit Over Diabetes Drugs
- Biden Order's New Lens Puts Foreign Transactions In Focus
- Viatris Investor Can Take Merger Suit Back To State Court
- Biopharma Co. Blasts 'Excessive' Fee Bid In Board Pay Case
- Longtime Federal Prosecutor Joins Troutman Pepper In Philly
- FTC Privacy Suit Tests Agency's Regulatory Authority
- Opioid MDL Attys To Get 'Much More Aggressive' As Talks Lag
- Feds Call Holmes' New Trial Bids 'Ploy' To Delay Sentencing
- UnitedHealth-Change Judge Outlines Why DOJ Lost
- Counterclaims Nixed In Drug Price Checker's Antitrust Suit
- Viatris Suppliers Want Out Of J&J Unit's MS Drug IP Suit
- Mass Tort Cases Expose Bankruptcy Courts To New Threats
- 1st Circ. Pick Vows To Apply Dobbs 'Faithfully'
- 1st Circ. Declines To Review Pot Interstate Commerce Ruling
- Key Adaptations For Law Firms Amid Quiet Quitting Movement
- 2nd Circ. Shkreli Atty Ruling Guides On 401(k) Garnishment
- Eli Lilly Seeks Exit From Workers' 401(k) Fees Class Action
- Genentech Agrees To 30K-Strong Class In 401(k) Fees Suit
- Proposed Hemp Tea Class Action Tossed By NJ Judge
- W.Va. AG Eyes $1B Opioid Haul As CVS, Walmart Pay $150M
- Portola Pharma Investors Ink $17.5M Deal Over Stock Declines
- Opana Direct Buyers' Attys Seek $50M Fees After $145M Deal
- CVS Wants NY's Illegal Service Tying Claims Tossed
- Abortion Rights Atty, A 1st Circ. Pick, May Face Tough Hearing
- Judge To Extend Block Of Ohio's 'Heartbeat' Abortion Law
- Fed. Circ. Won't Eye Novartis Case Flipped By Judge Change
- 2 SPACs Will Shut Down After Failed Searches
- FDA Hiding E-Cig Work 'In The Shadows,' Juul Suit Says
- Mylan Flags Claims Court Ruling In $50M Tax Fight At 3rd Circ.
- 3 Reasons Beauty Cos. Should Consider Pursuing Patents
- Fed. Contractor Says Glove Co. Hid Gov't Forced Labor Probe
- Terminix Investor Sues To Stop $6.7B Merger With Rentokil
- Creating A Hybrid Work Policy? Be Intentional And Inclusive
- 'Excessive' Atty Fee Bid In Ranbaxy MDL Slashed By $36M
- Imminent W.Va. Opioid Trial Delayed Amid New Suit, CVS Deal
- J&J's Talc Ch. 11 Case Was Bad Faith, Claimants Tell 3rd Circ.
- LabCorp Infringed Prenatal Test IP, Biotech Biz Tells Jury
- PTAB Wipes Out Cardiovalve's Heart Valve Implant Patent
- Vizgen Can't Escape Harvard, 10x's Patent Suit
- Cannabis Coverage Suit Belongs In Fed. Court, Insurers Say
- Biden Order Renews Spotlight On Advancement Of US Biotech
- Judge Won't Block UnitedHealth's Purchase Of Change
- BakerHostetler, Potter Anderson Trade Barbs In Board Battle
- Catching Up With Delaware's Chancery Court
- Judge Drops Five Plaintiffs From Juul MDL
- A Law Firm's Guide To Humane Layoffs As Recession Looms
- Jury Awards $363M In First Sterigenics Ethylene Oxide Trial
- Canadian Co. Can Exit Hemp Harvesting Machine Dispute
- Report Says 'Pervasive Abuse' Of Patents Boosts Drug Prices
- New CFIUS Order Will Prompt Broader Investment Scrutiny
- 50 Cent Sues Fla. Surgeon Over 'Penile Enhancement' Ads
- Chamber Seeks Biden Ax Of Wider WTO IP Deal
- Vanda Pharma Investors' $11.5M Deal Gets Judge's Initial OK
- US Gov't Sues Barge Insurer For $6.2M Oil Cleanup
- FCA Defendants Should Consider 'Collateral Hope' Defense
- Insurer Refuses To Defend Bakery In Ga. Poisoned Wells Suit
- BakerHostetler Blasts 'Misguided' Subpoena In Board Battle
- Marching In On Patents Under Bayh-Dole Would Gut Startups
- Judge Axes 2 Anti-Seizure Drug Patents, Upholds 3 Others
- 3rd Time May Be The Charm For Florida Cannabis Legalization
- Reverse Mergers Get Another Look As SPACs Decline
- Sterigenics Tells Ill. Jury That Emissions Science On Its Side
- FCA's 'Creative Lawyering' Defense Divides Full 4th Circ.
- Novartis Tells FDA Skinny Labels Won't Work With $3.5B Drug
- IP Forecast: PTAB To Eye Patent Tied To Intel's $2.2B Loss
- 2nd Circ. Won't Push $881M Cannabis IP Fight Into Arbitration
- Sanitizer Co. 4E Brands' Ch. 11 Plan Draws Creditor Objection
- Nev. Judge Orders Pot's Removal From State's Schedule I List
- Claim Construction Lessons In PTAB Fluid Energy Decision
- Shearman Partner Joins Caris Life Sciences As GC
- Fox Rothschild Grows Suburban Philly Outpost With IP Pro
- Boy Scouts Plan Confirmed, Cineworld Hits Ch. 11
- Sidley Adds Co-Founder Of Cooley's Shanghai Office In Calif.
- Drugmaker Akorn To Pay $7.9M For 'Rx-Only' Medicare Claims
- Biden Beefs Up Nat'l Security Evals For Foreign Investments
- Fla. Property Management Co.'s COVID Claims Tossed Again
- Holmes' New Trial Bid Is 'Mt. Everest' Uphill Fight, Attys Say
- Debevoise-Led AIG Spinoff Hits $1.68B In 2022's Biggest IPO
- Real Estate Rumors: UBS, Picus, Buzz Oates
- Faulty Food Engendered Mass Mice Euthanasia, NC Lab Says
- White House Details $2B Biotech Supply Chain Initiative
- Pharma Co. Challenges FDA's 'Uneven' Blood Drug Standards
- Spirit Air Can't Move Ahead With COVID-19 Coverage Suit
- What's Next For DOJ's COVID Enforcement In Health Care
- US Trustee Says Endo Can't Justify $71M In Bonus Pay
- White & Case-Led Apollomics To Go Public Via SPAC Merger
- Diagnostic Biz Investor Sues To Stop $1.53B Take-Private Sale
- Multiple Sclerosis Drug Kickback Case Against Novartis Axed
- Ohio Judge Temporarily Blocks 6-Week State Abortion Ban
- Walmart Settles W.Va. Opioid Case As Latest Trial Looms
- Sanofi Puerto Rico Unit Excused From Insulin Antitrust Case
- Loeb & Loeb Picks Up Regulatory Attorney In DC
- Learning From Trump And Bannon Discovery Strategies
- Abbott Unit Beats Ex-Worker's Appeal After Bias Trial Win
- Tulane, Insurer Gear Up For Trial In COVID-19 Coverage Row
- Sen. Graham's Federal Abortion Ban Gets GOP Cold Shoulder
- ITC Blocks Chinese Biotech Imports In Win For Ventria
- Women Sue Over Alleged Inaccurate Ovulation Test Kits
- 9th Circ. Says FDA Has Dibs On Copycat Drug Suits
- Gold Mine Ordered To Pay $500K For Polluting River In Colo.
- How To Minimize Risk When Launching Smart Medical Devices
- Green Groups Seek To Restart Fluoridated Water Risks Case
- Determining Assignor Estoppel After Hologic Patent Ruling
- Surgical Assistant Group Sues Board Over Accreditation
- AI Patent Survives PTAB Review After Getting Axed In WDTX
- Chancery Won't Delay Review Of Ionis Pharma Pay Suit Deal
- Waco IP Atty Calls Pilot License His 'Secret Weapon'
- CBD Co. Can't Slip Co-Founder's Suit Over $5M Tax Bill
- AstraZeneca Beats Investors' COVID Vaccine Suit For Good
- Korean Co. Can't Be First To Invent CRISPR, PTAB Told
- Customer Pledges, Lack Of Rivals Sunk FTC's Illumina Case
- FTC Asks About Credibility In Appeal Over Altria's Juul Deal
- Biden Aims To Boost Biotech In Latest Supply Chain Fix
- Gilead Settles HIV Drugs Patent Suit On Eve Of Bench Trial
- Ambry Genetics To Pay $12.25M To End Data Breach Suit
- Solicitor General Tells Justices To Pass On FCA Pleading Rule
- Lewis Brisbois Adds Toxic Tort Pros To Philly Office
- Endo Seeks Injunction To Pause Government Opioid Suits
- The Risks In Lateral Hiring, And How To Avoid Them
- Inside The Collapse Of A Pioneering Opioid Case For DOJ
- Abbott Infant Formula MDL Gets Co-Lead Plaintiffs' Attys
- Pfizer's $5.4B Deal To Acquire Drugmaker Faces Investor Suit
- WTO Dispute Roundup: Same Stalemate, New Solution
- Florida Pharma Co. Settles Drug Control Suit For $14.25M
- What Psychedelic Lawyers Can Learn From Pot Legalization
- Drugmaker Kickback Deal Isn't A Covered Loss, 7th Circ. Told
- AIG Spinoff's $1.8B Offering Kicks Off September IPO Lineup
- DLA Piper Adds FDA Adviser To Partner Ranks
- Medtronic Investors Sue Over Insulin Pump Recall, FDA Letter
- Patent Eligibility Reform May Require A Legislative Approach
- Health Hires: Bass Berry & Sims, Curebase
- 3rd Circ. Won't Resurrect False Ad Suit Over Medical Cream
- UK Litigation Roundup: Here's What You Missed In London
- Judges Who Use Social Media Must Know Their Ethical Limits
- IP Forecast: DC Circ. To Hear Free Speech Challenge To DMCA
- Holmes' 3rd New Trial Bid Targets Missing Database Emails
- Ohio Judge Questions Carveouts In 'Heartbeat' Abortion Law
- GenapSys Gets Court OK For $42M Sale To Investor Group
- SEC To Open New Office Scrutinizing Crypto Filings
- 3rd Circ. Won't Revive Off-Label Suit Over Teva Heart Drug
- Woman Gets 3.5 Years For 'Peddling Drugs' That Hurt Horses
- Baker Botts Snags Former Perkins Coie Managing Partner
- ABA Is Defending Profession's Values From Monied Influences
- Feds Can't Appeal Immunity Ruling In Flint Water Suit
- Bowman And Brooke Partner Discusses Expansion In Austin
- Cherokee Opioids Suit Can't Go To Okla. Court, 10th Circ. Told
- McGuireWoods Adds 2 Patent Pros From Winston & Strawn
- King & Spalding Litigation Team Joins Hogan Lovells In SF
- FTC Says Endo Bankruptcy Can't Stop DC Circ. Appeal
- Elizabeth Holmes Files 2nd New Trial Bid, Citing Balwani Trial
- Analytics Co. Hit With Consumer Suit In Wake Of FTC Action
- Shipping Co. Can't Escape $200M Suit Over Deadly Explosion
- Teva Tells Justices $235M Loss 'Erodes' Patent Law
- Bayer Beats Former Exec's Retaliation Suit At 3rd Circ.
- CVS, Walgreens, Walmart Will Fight $650M Ohio Opioid Order
- How In-House Counsel Can Better Manage Litigation Exposure
- Ill. Pharma Co. Gets OK For Fast Sale Of Testosterone Drug
- Grocer's Amended Suit Stalls Opioid Coverage Ruling
- Merck, Glenmark Antitrust MDL Must Go To Jury, Judge Says
- SF Supervisors OK Psychedelics Decriminalization Measure
- Sidley Taps Former SoftBank Director As Partner In SF
- K&L Gates Clean Energy Projects Atty Jumps To Baker Botts
- J&J, Former Exec Agree To End Workplace Bias Suit
- Pharmacist May Need Third Sentencing In Meningitis Case
- 'Ponzi' Cannabis Extract Suit Belongs In NC, Calif. Judge Says
- Ohio Justices Nix Insurer's Duty To Defend In Opioid Suits
- Pharmacies Flooded NM With Opioids, AG Says As Trial Starts
- Bass Berry 'Lacked Courtesy' As Atty Grieved, DOJ Says
- Ex-Invisalign VP Scored $349K Via Insider Trading, SEC Says
- SEC Fines NY Adviser $1.5M Over Alleged SPAC Conflicts
- 3rd Circ. Panel Questions Niaspan Buyers' Class Data
- Polsinelli Beats Malpractice Suit By Pharma Co., Ex-CEO
- Geron Investors Ink $24M Deal Over Cancer Study Results
- Catching Up With Delaware's Chancery Court
- Ch. 11 Cheat Sheet: Clarus Therapeutics
- Practical E-Discovery Lessons From The Alex Jones Case
- Holmes Wants New Trial After Key Witness Expresses Regrets
- Why Creditors Should Beware Of SBRA Due Diligence Defense
- Barnes & Thornburg Hires Faegre Drinker Team In Philly, NJ
- Pharma Co. Clarus Hits Ch. 11 With Plan To Sell Sole Drug
- EU Bans Illumina's $8B Acquisition Of Grail
- Law360 MVP Awards Go To 188 Attys From 78 Firms
- The Hottest Topics For Health Attys In 2022's Homestretch
- NY Grants $6.5M For Climate Change Insurance Innovation
- Breach Victim Facing 'Imminent' Harm Can Sue, 3rd Circ. Says
- Ohio Clinics Shift Gears In Abortion Ban Challenge
- After Dobbs: State Abortion Ban Fights, Enforcement Heat Up
- USPTO Eases Access To Patents Affected By FDA Delays
- FTC Appealing Judge's Ruling On Illumina's $8B Grail Deal
- Bayer Strikes $40M Deal, Ending 17-Year FCA Saga
- J&J And Ethicon Fight Attempt At New Pelvic Mesh Trial
- 3rd Circ. Preview: J&J Unit, Pipeline Fights On Sept. Docket
- Gov't Wants Max Sentence For Convicted Horse PED Seller
- The Ethical Risks For Lawyers Accepting Payments In Crypto
- Sears, Boy Scouts Each Move Closer To Ch. 11 Resolutions
- Biden Nominates Montana Law Professor For 9th Circ.
- Jury Convicts Arrayit Exec Of Fraud For COVID Test Lies
- EU And Turkey Show How To Break WTO Appeal Impasse
- Harsh Market Limits IPO Prospects For Autumn Listings
- CDC Signs Off On Omicron-Specific COVID Booster Shots
- Philips Unit To Pay $24M To End Med. Supply Kickback Case
- Judge Axes 1 Tyvaso Patent, Finds Another Was Infringed
- Eli Lilly Wants New Trial Over Medicaid Rebate Calculations
- IP Forecast: Patent Biz To Fight For Its Right To Keep Suing
- Monsanto Gets Fast Win In St. Louis Roundup Trial
- Davis Polk, Goodwin Steer $1.1B Novo Nordisk Acquisition
- J&J Reaches $40.5M Opioid Deal With NH, Avoiding Trial
- Maine Pot Org. Seeks Rehearing Of Commerce Clause Ruling
- Bard Can't Escape $3.3M Vein Filter Verdict
- Citing Pot's Illegality, Co. Seeks Quick Win In Patent Row
- Holmes Acquittal Bid Denied As Attys Hint At New Info
- Compliance Considerations For Telehealth Abortion Services
- Envisioning Metaverse-Based Litigation In The Real World
- Cosmetics Cos. Invite Legal Risks With 'Clean' Marketing
- What May Lie Ahead For ITC Trade Secret Claims
- PerkinElmer Says Lab Owes $6M For COVID Test Gear
- FTC Judge Rejects Challenge To Illumina's $8B Grail Deal